Dr. Vijil Rahulan

Qualification:

• Diplomate of American Board of Internal Medicine, Pulmonary and Critical Care Medicine
• Graduated from Armed Forces Medical College, Pune 1993.
• Residency in Internal Medicine and Fellowship in Pulmonary Medicine from Albert Einstein College of Medicine, New York, USA.
• Fellowship in Critical Care medicine from Wayne State University, Detroit, Michigan, USA.
• Further training in Interventional Pulmonology at Lahey Clinic, Massachusetts, USA and in Lung Transplantation at Barnes Jewish Medical Center, St Louis, Missouri, USA.
• Seven years of full time consultative practice experience in USA in the field of Pulmonolgy, Critical Care and Sleep Medicine.
• Current Position:Additional Director, KIMS Heart & Lung Transplant Institute
• Chief, Transplant Pulmonology, Krishna Institute of Medical Sciences, Minister Road, Secunderabad, Telangana, India ( from June 2020)
• Formerly H.O.D, Pulmonary/Critical Care & Senior Transplant Pulmonologist

     Institute of Pulmonary, Critical Care Medicine & Lung Transplantation At Gleneagles Global Health city, Chennai (from 2009 till May       2020)

Recognition:

Publications:

Has published several research papers in reputed international journals in the field of Pulmonlogy Medicine and Lung Transplantation

First Series of Combined Heart & Lung Transplantation from India

April 2020, The Journal of Heart and Lung Transplantation39(4):S387

DOI: 10.1016/j.healun.2020.01.505

AIRWAY COMPLICATIONS POST LUNG TRANSPLANTATION: LARGEST SINGLE CENTER INDIAN EXPERIENCE

June 2020, CHEST 157(6):A450

DOI:10.1016/j.chest.2020.05.510

Tailored Immunosuppression Using CYP3A5 Metaboliser Status in Heart and Lung Transplant Cases - An Indian Study

April 2020, The Journal of Heart and Lung Transplantation39(4):S504

DOI: 10.1016/j.healun.2020.01.107

Pulmonary alveolar microlithiasis: A rare disease treated with lung transplantation, first case from India

November 2019, Lung India 36(6):546

DOI: 10.4103/lungindia.lungindia_50_19

Correlation of Tacrolimus Levels and Metabolizer Status Based on CYP3A5 Polymorphism in Indian Lung Transplant Recipients

April 2019, The Journal of Heart and Lung Transplantation38(4):S410

DOI: 10.1016/j.healun.2019.01.1045

A real life experience on the efficacy and safety of mycophenolatemofetil in connective tissue disorder associated interstitial lung disease – a retrospective study

June 2018, Annals of the Rheumatic Diseases 77(Suppl 2):1533-1533

DOI: 10.1136/annrheumdis-2018-eular.3395

Establishing a Lung Transplant Program in a Resource Constrained Setting

April 2018, The Journal of Heart and Lung Transplantation37(4):S255

DOI:10.1016/j.healun.2018.01.635

Complications and management of attempted suicide by intrapleural injection of prallethrin

March 2016, Indian Journal of Critical Care Medicine20(3):182

DOI:10.4103/0972-5229.178184

Single lung transplantation in India: an initial experience

September 2013, The Indian journal of chest diseases & allied sciences 55(2):101-3

Endobronchial cryptococcosis: A rare cause of lung collapse

January 2010, Journal of Bronchology and Interventional Pulmonology 17(1):76-9

DOI:10.1097/LBR.0b013e3181cd95da